Vimarsana
Biggest News Aggregation in the World

Universal Oil News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universal Oil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universal Oil Today - Breaking & Trending Today

Calanthean Temple:Its history, importance to Shreveport - Vimarsana News

Calanthean Temple:Its history, importance to Shreveport

SHREVEPORT, La. -- When people hear the name Calanthean Temple, they might think of a religious observance, but it’s not. It’s a business incubator, according to Shreveport tour guide and

Source: ktbs.com
Shreveport was home to first black-owned oil company in the U.S. - Vimarsana News

Shreveport was home to first black-owned oil company in the U.S.

Universal Oil, Gas and Mining Company was the first black-owned oil company in the United States. Its headquarters was located at 1051 ½ Texas Avenue in Shreveport. UOGMC got its start at the very beginning of the Great Depression, when the company had only $20 left in its entire treasury after paperwork was filed for the charter.

Source: wkrg.com
GlaxoSmithKline Files Amicus Brief in Amgen v. Sanofi | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

GlaxoSmithKline Files Amicus Brief in Amgen v. Sanofi | McDonnell Boehnen Hulbert & Berghoff LLP

The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure...

Scalp-care products: 10 of the best - Vimarsana News

Scalp-care products: 10 of the best

This trend is worth taking seriously: a healthy scalp will produce beautiful hair. By Funmi Fetto

Amgen Files Its Principal Brief in Amgen v. Sanofi | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Amgen Files Its Principal Brief in Amgen v. Sanofi | McDonnell Boehnen Hulbert & Berghoff LLP

Facing what is likely to be something of an uphill battle in seeking to have the Federal Circuit's decision against it in Amgen v Sanofi overturned before a not always patent-friendly...